FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Partners: Universiteit Antwerpen – (UA)

The organisation

UAUA is the third largest university in Flanders, enrolling ~12’000 students each academic year. To promote research in a limited number of strategic scientific domains, the UA set in place a number of Centres of Excellence. In the field of biomedical sciences these include The Vaccine and Infectious Disease Institute (Vaxinfectio; headed by Prof. Herman Goossens; involved in the SATURN project). Furthermore, the UA houses Core Facilities providing expert technological support like The Genetic Service Facility, The Centre for Proteomics and several others.

Key staff involved in the project

Herman GoossensHerman Goossens, Professor (MD, PhD) is a professor of Medical Microbiology at the University of Antwerp, and head of the department of Medical Microbiology at the University Hospital Antwerp. He is also head of the recently founded (December 2007) Vaccine & Infectious Disease Institute (Vaxinfectio). As a researcher, he has extensive experience in mechanisms of AMR and antimicrobial use, molecular epidemiology and molecular diagnostics. On these issues, he has published >300 papers in peer-reviewed scientific journals. He is the coordinator of GRACE (FP6) and ESAC (funded by ECDC), and he is participating in several EU funded projects (MOSAR, and CHAMP - FP6; TheraEDGE, InTopSens, and APRES - FP7).

Surbhi Malhotra-KumarSurbhi Malhotra-Kumar, Dr. (MS Medical Microbiology, MS Molecular Biology, PhD) is a senior post-doctoral fellow funded by the Flemish government (Funds for Scientific Research, Flanders). She has received several awards (Eugène Yourassowsky Prize, Research Fellowship from the European Society for Microbiology and Infectious Diseases (ESCMID), and Joint Fellowship from ESCMID and Federation of European Microbiological Sciences (FEMS)) for scientific excellence. She is currently participating in several EU-funded projects (MOSAR, InTopSens, TheraEDGE). Her work focuses on the epidemiology and molecular mechanisms of antibiotic resistance and developing diagnostic tests for the rapid detection of pathogens causing community-acquired and nosocomial infections.

Samuel CoenenSamuel Coenen, Professor (MD, PhD) is the research coordinator of the Centre for General Practice at the University of Antwerp, and Honorary Research Fellow of the University of Cardiff.  As (postdoctoral) research fellow of the Research Foundation – Flanders (1997-2009) and member of the GRACE (FP6) and ESAC (funded by ECDC) management team, his research has focused on the management of respiratory infections and appropriate antibiotic use in primary care.  He is also actively involved in e.g. BAPCOC, GRIN, CHAMP (FP6), APRES (FP7).

Niels AdriaenssensNiels Adriaenssens, (MD-) is a PhD student with expertise in outpatient antimicrobial consumption and the management of respiratory infections in primary care.  He is member of the ESAC management team and national network facilitator of the Antwerp primary care research network for GRACE.

Jascha VervoortJascha Vervoort, (MS Biochemistry & Biotechnology) is a PhD student with expertise in molecular biology and genetics.

Christine Lammens, head of technical staff at LMM, has extensive experience in both conventional and molecular techniques. She is actively involved in the logistic management of several European projects and has built up a large experience in this field.

Further information

www.ua.ac.be/vaxinfectio

Top ^